research Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
Ritlecitinib effectively treats alopecia areata and is well-tolerated.


Bucaramanga, Colombia
Rome, Italy
Quarto Oggiaro, Italy
Houston, TX, United States
Incomplete name
Philadelphia, PA, United States
Chandigarh, Chandigarh, India